サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1793787

呼吸器内治療器の世界市場

Respiratory Endotherapy Devices

出版日
ページ情報
英文 381 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
呼吸器内治療器の世界市場
出版日: 2025年08月19日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 381 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

呼吸器内治療器の世界市場は2030年までに17億米ドルに達する

2024年に14億米ドルと推定される呼吸器内治療器の世界市場は、分析期間2024-2030年にCAGR 3.6%で成長し、2030年には17億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである診断機器は、CAGR 2.9%を記録し、分析期間終了までに10億米ドルに達すると予測されます。治療機器セグメントの成長率は、分析期間中CAGR 4.7%と推定されます。

米国市場は推定3億8,330万米ドル、中国はCAGR6.6％で成長予測

米国の呼吸器内治療器市場は、2024年に3億8,330万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに3億4,650万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の呼吸器内治療器市場- 主要動向と促進要因まとめ

気道の内側技術の進歩が肺のインターベンショナル手技をどう変えるか

慢性・急性呼吸器疾患管理における内視鏡治療の役割を高めるものとは？

慢性および急性の気道障害の診断と治療において、呼吸器内科がより低侵襲で精密な誘導による治療へと移行するにつれて、呼吸器内治療器市場は急速に注目を集めています。慢性閉塞性肺疾患（COPD）、気管支狭窄、中枢性気道閉塞、肺がんなどの疾患では、閉塞した気道の拡張、ステント留置、切除を含む治療的内視鏡検査が必要となることが多いです。これらの治療は、バルーン拡張器、電気外科用プローブ、凍結療法システム、気道ステントなどの高度な内視鏡治療機器を用いて行われることが多くなってきており、周辺組織への外傷を最小限に抑えた標的治療を可能にしています。

都市公害、喫煙、高齢化、COVID後の合併症によって悪化した呼吸器疾患の負担の増大により、大手術に頼らずに呼吸器疾患を緩和する技術が急務となっています。この点で、内視鏡治療は、外来での治療が可能であること、回復に要する時間が短いこと、合併症のリスクが低いことなど、いくつかの利点があります。例えば肺がんの場合、気管支鏡による治療は緩和的な減圧だけでなく、光線力学的治療やブラキセラピーなどの局所治療にも用いられるようになってきています。このようなシフトは、手技の安全性と診断精度を向上させる画像誘導ナビゲーションと小型化された器具の改良によって支えられており、肺専門医はより高い精度でより深い肺セグメントにアクセスすることができます。

内視鏡治療機器の性能を変える機器と画像診断の革新とは？

技術革新は、呼吸器内治療器の性能、デザイン、アプリケーションを再構築しています。主な進歩の一つは、複雑な気道解剖におけるナビゲーションを向上させながら交差汚染のリスクを低減する、ステアラブルな使い捨て気管支鏡の開発です。これらの使い捨てデバイスは、リアルタイムの透視システムや電磁ナビゲーションシステムと組み合わされ、臨床医が以前はアクセスできなかった病変に治療を行うことを可能にします。さらに、膨張プロファイルが調整可能なバルーン拡張システムは、段階的な圧力制御を可能にし、拡張処置中の気道外傷のリスクを低減しています。

もう一つの重要な動向は、電気外科および冷凍アブレーション装置の小型化と気管支鏡プラットフォームへの統合です。生検や切除のために異常組織を正確に凍結することができるクライオプローブは、末梢肺の処置に適した柔軟な形態で利用できるようになりました。同様に、アルゴンプラズマ凝固療法（APC）やラジオ波焼灼療法（RFA）も、喀血の抑制や腫瘍の除去のために経気管支用に適応されつつあります。高度なステントデリバリーシステム（多くの場合、あらかじめ装填され、自己拡張し、長さや直径をカスタマイズできる）は、気道狭窄や手術後の狭窄の治療成績を向上させています。さらに、内視鏡治療器具は、温度、圧力、位置決めに関するリアルタイムのフィードバックを得るためのセンサーを組み込んで設計されるようになってきており、これによって人為的ミスを最小限に抑え、手技の再現性を高めています。

臨床プロトコールと地域ヘルスケアインフラは市場浸透をどのように形成するか？

呼吸器内治療器の普及は、地域の臨床プロトコル、償還の枠組み、インターベンショナル・パルモノロジー・インフラストラクチャの有無に大きく影響されます。米国、ドイツ、日本、韓国などの高所得地域では、呼吸器内治療が診断と治療の両方の目的で三次医療センターで標準治療として採用されるようになってきています。これらの国の病院には、高度な画像診断装置、統合された手術室、あらゆる機器を利用できる訓練を受けたインターベンショナル・パーモニストなどが備わっています。これらの地域では、低侵襲手技や急性期後の呼吸器ケアに対する償還も確立しており、導入がさらに促進されています。

対照的に、東南アジア、東欧、ラテンアメリカなどの中所得地域では、呼吸器内治療への関心が高まっているが、費用面や限られた技術的専門知識によって、導入が制約されることが多いです。とはいえ、官民パートナーシップの拡大や遠隔医療ベースのトレーニングプラットフォームが、技術格差の解消に役立っています。インド、中国、ブラジルでは、呼吸器疾患の早期発見・早期管理を目標とする政府や非営利団体のイニシアチブが、費用対効果が高く、現地に適応した内視鏡治療ソリューションの需要に拍車をかけています。都市部の病院では、移動式の気管支鏡検査ユニットや外来インターベンション・プログラムが登場し始めており、より幅広い患者層が内視鏡治療にアクセスできるようになっています。

呼吸器内治療器市場の長期的成長を支えるものは何か？

呼吸器内治療器市場の成長は、慢性呼吸器疾患の有病率の増加、低侵襲的介入に対する需要の高まり、処置ツールの継続的な技術革新など、いくつかの要因によってもたらされます。主な成長要因は、外来治療モデルや外来患者への介入へのシフトです。ヘルスケアシステムは入院コストと外科的合併症の削減を迫られており、気管支鏡内視鏡治療はバリューベースケアの目標に沿った実行可能な代替手段を提供します。気管支内視鏡治療の需要は、低線量CTスキャンやAI支援X線検査によって発見されることの多い呼吸器・胸部疾患の早期診断の増加によってさらに高まっています。

加えて、インターベンショナル・パスモノロジーが明確なサブスペシャリティとして果たす役割の拡大により、先進的な内視鏡治療ツールを採用するための強固な臨床基盤が形成されつつあります。病院やトレーニングセンターは、新世代の肺専門医をサポートするために、シミュレーションラボ、ハイブリッド手術室、AIガイド付き手技計画システムに投資しています。技術面では、ロボット工学、画像診断、材料科学の融合が進んでおり、自律走行ナビゲーション、高精度ドラッグデリバリー、抗炎症特性を持つナノコートステントなどの可能性が開花しつつあります。

最後に、WHOの「NCDsの予防と制御のための世界・アクション・プラン」など、呼吸器の健康に焦点を当てた世界の保健政策イニシアチブは、この分野への投資と技術革新に有利な政策環境を作り出しています。人口の高齢化、都市部での罹患率の上昇、呼吸器パンデミックの継続的な脅威により、肺の健康管理における内視鏡治療の役割は大きく成長することが予想されます。今後の医療機器は、より手頃な価格で、個別化され、デジタル接続されるようになり、この影響力の大きい医療分野の長期的な成長軌道が確保されると予想されます。

セグメント

機器（診断機器、治療機器）、専門家（病院専門家、診断センター専門家、外来手術センター専門家）、エンドユーザー（末梢血管インターベンションエンドユーザー、血管内インターベンションエンドユーザー、心臓エンドユーザー、インターベンショナルラジオロジーエンドユーザー、静脈エンドユーザー、その他エンドユーザー）

調査対象企業の例

  • Ambu
  • Armstrong Medical
  • Boston Scientific
  • CONMED Corporation
  • Cook Medical
  • Dragerwerk
  • Fisher & Paykel Healthcare
  • Flexicare Medical
  • Getinge
  • Halyard Health（Avanos Medical）
  • Hudson RCI
  • Intersurgical
  • Karl Storz
  • Laerdal Medical
  • Medtronic
  • Olympus
  • PENTAX Medical
  • Philips（Philips Respironics）
  • ResMed
  • Teleflex

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37917

Global Respiratory Endotherapy Devices Market to Reach US$1.7 Billion by 2030

The global market for Respiratory Endotherapy Devices estimated at US$1.4 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Therapeutic Devices segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$383.3 Million While China is Forecast to Grow at 6.6% CAGR

The Respiratory Endotherapy Devices market in the U.S. is estimated at US$383.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$346.5 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Respiratory Endotherapy Devices Market - Key Trends & Drivers Summarized

Inside the Airway: How Technological Advancements Are Transforming Interventional Pulmonary Procedures

What Is Elevating the Role of Endotherapy in Managing Chronic and Acute Respiratory Disorders?

The respiratory endotherapy devices market is rapidly gaining prominence as pulmonology transitions toward less invasive, precision-guided interventions for the diagnosis and treatment of both chronic and acute airway disorders. Conditions such as chronic obstructive pulmonary disease (COPD), bronchial stenosis, central airway obstruction, and lung cancers often require therapeutic endoscopy involving dilation, stenting, or ablation of obstructed airways. These interventions are increasingly being performed using advanced endotherapy devices, including balloon dilators, electrosurgical probes, cryotherapy systems, and airway stents, which enable targeted treatment with minimal trauma to surrounding tissues.

The rising burden of respiratory diseases-exacerbated by urban pollution, smoking, aging populations, and post-COVID complications-has created an urgent need for technologies that provide relief without resorting to major surgery. Endotherapy offers several advantages in this regard, such as outpatient feasibility, shorter recovery time, and lower risk of complications. In the context of lung cancer, for instance, bronchoscopic interventions are being used not only for palliative decompression but also for delivering localized therapy such as photodynamic treatment or brachytherapy. These shifts are supported by improvements in imaging-guided navigation and miniaturized instrumentation that enhance procedural safety and diagnostic accuracy, allowing pulmonologists to access deeper lung segments with higher precision.

What Innovations in Instrumentation and Imaging Are Transforming Endotherapy Device Performance?

Technological innovation is reshaping the performance, design, and application of respiratory endotherapy devices. One of the major advancements is the development of steerable, single-use bronchoscopes that reduce cross-contamination risks while improving navigation in complex airway anatomies. These disposable devices, paired with real-time fluoroscopy or electromagnetic navigation systems, enable clinicians to deliver therapy to previously inaccessible lesions. Moreover, balloon dilation systems with adjustable inflation profiles now provide graduated pressure control, reducing the risk of airway trauma during dilation procedures.

Another significant trend is the miniaturization and integration of electrosurgical and cryoablation devices into bronchoscopic platforms. Cryoprobes, capable of precisely freezing abnormal tissue for biopsy or ablation, are now available in flexible formats suitable for peripheral lung procedures. Similarly, argon plasma coagulation (APC) and radiofrequency ablation (RFA) tools are being adapted for transbronchial use to control hemoptysis or debulk tumors. Advanced stent delivery systems-often preloaded, self-expanding, and customizable in length and diameter-are improving treatment outcomes in airway stenosis and post-surgical strictures. Furthermore, endotherapy devices are now being designed with embedded sensors for real-time feedback on temperature, pressure, and positioning, thereby minimizing human error and enhancing procedural reproducibility.

How Do Clinical Protocols and Regional Healthcare Infrastructure Shape Market Penetration?

The adoption of respiratory endotherapy devices is highly influenced by local clinical protocols, reimbursement frameworks, and the availability of interventional pulmonology infrastructure. In high-income regions such as the U.S., Germany, Japan, and South Korea, respiratory endotherapy is increasingly being adopted as standard-of-care in tertiary centers for both diagnostic and therapeutic purposes. Hospitals in these countries are equipped with advanced imaging modalities, integrated operating suites, and trained interventional pulmonologists who can utilize the full spectrum of devices. Reimbursement for minimally invasive procedures and post-acute respiratory care is also well established in these regions, further encouraging adoption.

In contrast, middle-income regions such as Southeast Asia, Eastern Europe, and Latin America are witnessing growing interest in respiratory endotherapy, but uptake is often constrained by cost considerations and limited technical expertise. Nevertheless, the expansion of public-private partnerships and telemedicine-based training platforms is helping to bridge the skills gap. In India, China, and Brazil, government and non-profit initiatives targeting early detection and management of respiratory diseases are spurring demand for cost-effective, locally adapted endotherapy solutions. Mobile bronchoscopy units and outpatient interventional programs are beginning to appear in urban hospitals, bringing endotherapy within reach of a broader patient demographic.

What Is Sustaining Long-Term Growth in the Respiratory Endotherapy Devices Market?

The growth in the respiratory endotherapy devices market is driven by several factors, including the increasing prevalence of chronic respiratory diseases, rising demand for minimally invasive interventions, and ongoing innovation in procedural tools. A major growth driver is the shift toward ambulatory care models and outpatient interventions. With healthcare systems under pressure to reduce inpatient costs and surgical complications, bronchoscopic endotherapy provides a viable alternative that aligns with the goals of value-based care. The demand for these procedures is further fueled by the rise in early diagnosis of respiratory and thoracic conditions, often detected through low-dose CT scans and AI-assisted radiology.

In addition, the expanding role of interventional pulmonology as a distinct subspecialty is creating a robust clinical base for the adoption of advanced endotherapy tools. Hospitals and training centers are investing in simulation labs, hybrid ORs, and AI-guided procedural planning systems to support a new generation of pulmonary specialists. From a technology standpoint, the ongoing convergence of robotics, imaging, and material science is unlocking possibilities such as autonomous navigation, precision drug delivery, and nanocoated stents with anti-inflammatory properties.

Finally, global health policy initiatives focusing on respiratory health-such as the WHO’s Global Action Plan for the Prevention and Control of NCDs-are creating a favorable policy environment for investment and innovation in this domain. With aging populations, rising urban morbidity, and the continuing threat of respiratory pandemics, the role of endotherapy in managing pulmonary health is set to grow substantially. Future devices are expected to become more affordable, personalized, and digitally connected, securing a long-term trajectory of growth for this high-impact medical segment.

SCOPE OF STUDY:

The report analyzes the Respiratory Endotherapy Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Diagnostic Devices, Therapeutic Devices); Specialist (Hospitals Specialist, Diagnostic Centers Specialist, Ambulatory Surgery Centers Specialist); End-Use (Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use, Interventional Radiology End-Use, Venous End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Ambu
  • Armstrong Medical
  • Boston Scientific
  • CONMED Corporation
  • Cook Medical
  • Dragerwerk
  • Fisher & Paykel Healthcare
  • Flexicare Medical
  • Getinge
  • Halyard Health (Avanos Medical)
  • Hudson RCI
  • Intersurgical
  • Karl Storz
  • Laerdal Medical
  • Medtronic
  • Olympus
  • PENTAX Medical
  • Philips (Philips Respironics)
  • ResMed
  • Teleflex

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Respiratory Endotherapy Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Respiratory Diseases Propels Demand for Endotherapy Interventions
    • Aging Global Population Base Strengthens Business Case for Minimally Invasive Pulmonary Procedures
    • Increased Diagnosis Rates of COPD and Asthma Accelerate Device Utilization in Bronchoscopic Therapies
    • Advances in Flexible Endoscopic Technologies Expand Addressable Market for Precision Treatment
    • Surge in Demand for Non-Surgical Alternatives Spurs Adoption of Respiratory Endotherapy Devices
    • Integration of Imaging-Guided Navigation Systems Enhances Procedure Success and Market Uptake
    • Emergence of Endobronchial Valves and Coils Drives Innovation in Severe Emphysema Treatment
    • Growing Focus on Daycare and Outpatient Bronchoscopy Strengthens Demand for Disposable Instruments
    • Hospital Budget Constraints Propel Preference for Reusable and Sterilizable Device Configurations
    • Expanding Adoption in Lung Cancer Diagnosis and Palliative Care Broadens Use-Case Scenarios
    • Clinical Trials and Regulatory Approvals Accelerate Market Penetration of Novel Endotherapy Solutions
    • Public and Private Investment in Respiratory Research Fuels Device Development Pipelines
    • Increased Demand for Airway Stenting and Dilatation Enhances Market Versatility
    • High Burden of Smoking-Related Lung Damage Throws the Spotlight on Therapeutic Endoscopy
    • Integration with AI-Based Bronchoscopic Mapping Systems Drives Procedural Efficiency
    • Surge in ICU Admissions and Ventilation-Related Complications Boosts Procedural Frequency
    • Training and Simulation Tools Enhance Adoption Rates Among Pulmonologists and Interventionalists
    • Decentralization of Respiratory Care to Ambulatory Settings Expands Market Reach
    • Innovations in Biodegradable Implants Open New Frontiers in Chronic Disease Management
    • Rising Healthcare Spending in Emerging Markets Spurs Procurement of Advanced Endotherapy Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Respiratory Endotherapy Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Respiratory Endotherapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Therapeutic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Therapeutic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Venous End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Venous End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Venous End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Peripheral Vascular Intervention End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Peripheral Vascular Intervention End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Peripheral Vascular Intervention End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Endovascular Interventions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Endovascular Interventions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Endovascular Interventions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cardiac End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cardiac End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Cardiac End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Interventional Radiology End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Interventional Radiology End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Interventional Radiology End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Diagnostic Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Diagnostic Centers Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ambulatory Surgery Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • JAPAN
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • CHINA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: China 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • EUROPE
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Respiratory Endotherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • FRANCE
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: France 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • GERMANY
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • INDIA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: India 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Respiratory Endotherapy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Respiratory Endotherapy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
  • AFRICA
    • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030

IV. COMPETITION